Chinese maker of recombinant proteins, antibodies and reagents used in life-science research.
Chinese maker of recombinant proteins, antibodies and reagents used in life-science research.
In one line: A China-based life-science reagents supplier.
Moat: narrow (scale, process know-how). Broad reagent catalog and manufacturing scale versus smaller domestic peers.
Headquarters: Suzhou, China · Employees: 636
Size Suzhou Novoprotein Scientific (688137.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.12B, the 1934th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥105.00 on 18 Nov 2026.
Performance Over six months the shares gained 117.5%, against -20.9% for the median peer and -20.0% for the China market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue grew 8.1% over the last twelve months (peer median +7.9%); the operating margin is -61.6% (peer median 11.4%).
Valuation It trades at 42.8× enterprise value to sales against a peer median of 2.5× (most expensive of 21).
Capital Return on invested capital runs 14.9 points below its cost of capital (10.6% WACC).
Next results Next results expected around 4 May 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥159M | CN¥146M | CN¥126M | CN¥153M | CN¥262M |
| Revenue growth | — | +15% | -17% | -42% | — |
| Gross profit | CN¥126M | CN¥81.7M | CN¥60.3M | CN¥105M | CN¥216M |
| EBITDA | n/a | -CN¥59.2M | -CN¥63.4M | -CN¥25.7M | CN¥104M |
| Net income | -CN¥96.8M | -CN¥77.8M | -CN¥54.4M | CN¥12.8M | CN¥90.7M |
| Free cash flow | -CN¥173M | -CN¥61.2M | -CN¥15.4M | CN¥44.3M | -CN¥32.8M |
| Capital expenditure | CN¥164M | CN¥78.9M | CN¥44.9M | CN¥44.9M | CN¥36.8M |
| Total debt | CN¥47.8M | CN¥55.6M | CN¥66.4M | CN¥73.3M | CN¥83.1M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688137.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -19.4% | -8.8% | 6th lowest of 21 |
| 6-month return | +117.5% | -20.9% | highest of 21 |
| Distance from 52-week high | -37.5% | -41.1% | 10th highest of 21 |
| Revenue growth (TTM) | +8.1% | +7.9% | 11th highest of 21 |
| Operating margin | -61.6% | 11.4% | lowest of 21 |
| EV / Sales | 42.8× | 2.5× | most expensive of 21 |
| ROIC minus cost of capital | -14.9 pp | +1.6 pp | 2nd lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Suzhou Novoprotein Scientific 688137.SS | China | $1.12B | +117% | +8% | -62% | 42.8× | n/a | n/a |
| Willdan WLDN | United States | $1.13B | -20% | +19% | 7% | 1.5× | 17.2% | +11.8% |
| Vcanbio Cell & Gene Engineering 600645.SS | China | $1.11B | -29% | -6% | 12% | 4.1× | 8.9% | +1.9% |
| Jadard Technology 688252.SS | China | $1.14B | -22% | +6% | 12% | 2.5× | 12.0% | +31.3% |
| FESCO 600861.SS | China | $1.10B | -15% | +4% | 1% | 0.0× | n/a | n/a |
| Resolute Holdings Management RHLD | United States | $1.16B | +34% | +10% | 12% | 4.2× | 16.6% | n/a |
| China East Education 0667.HK | Hong Kong | $1.09B | -21% | +16% | 22% | 1.1× | -7.5% | +4.1% |
| Nittetsu Mining 1515.T | Japan | $1.17B | -3% | +18% | 8% | 1.0× | n/a | n/a |
| Prosegur Cash CASH.MC | Spain | $1.07B | +10% | -2% | 11% | 0.9× | -12.1% | +5.7% |
| Shanxi Huaxiang 603112.SS | China | $1.19B | -33% | +9% | 11% | 1.8× | 0.9% | +16.2% |
| Siglent Technologies 688112.SS | China | $1.19B | -26% | +30% | 24% | 9.1× | 27.7% | +22.0% |
| SBT Ultrasonic Technology 688392.SS | China | $1.06B | -36% | +42% | 17% | 6.5× | n/a | n/a |
| Bajaj Mobility BMAG.SW | Switzerland | $1.05B | +40% | -47% | -44% | 1.8× | n/a | n/a |
| Neurones NRO.PA | France | $1.03B | +3% | +7% | 9% | 0.8× | -7.9% | +10.3% |
| DOOSAN TESNA 131970.KS | South Korea | $1.03B | -62% | +5% | 10% | 5.0× | n/a | n/a |
| Service Stream SSM.AX | Australia | $1.03B | -9% | +1% | 3% | 0.7× | 13.9% | +24.0% |
| Naruida Technology 688522.SS | China | $1.01B | -32% | +20% | 14% | 9.4× | n/a | n/a |
| Concord Biotech CONCORDBIO.NS | India | $1.26B | -2% | +4% | 28% | 9.7× | 44.4% | +11.6% |
| Suzhou Recodeal Interconnect System 688800.SS | China | $1.26B | -68% | +5% | 9% | 2.6× | 22.7% | +38.9% |
| EMTEK (Shenzhen) 300938.SZ | China | $1,000M | -54% | +11% | 27% | 7.7× | n/a | n/a |
| Smartgroup SIQ.AX | Australia | $986M | -6% | +10% | 37% | 3.6× | -1.3% | +8.8% |